Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Allergan’s Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research

      Americas
      Allergan plc , a leading global pharmaceutical company, is pleased to announce that its manuscript, "Fluctuations in Episodic and Chronic Migraine Status Over the...

      Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002

      FDA Approvals
      Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a new clinical...

      Daiichi Sankyo Launches Anticoagulant LixianaⓇ OD Tablets (orally disintegrating tablets) in Japan

      Americas
      Daiichi Sankyo Company, Limited announced that it has launched its oral anticoagulant LixianaⓇ OD Tablets 15 mg, 30 mg and 60 mg (generic name:...

      Merck Receives FDA Approval for ISENTRESS , in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection

      FDA Approvals
      Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir), the company’s integrase inhibitor,...

      Stealth BioTherapeutics Granted Fast Track Designation For The Treatment Of Barth Syndrome

      Americas
      Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has...

      Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Neutrolis, Remora Therapeutics

      Americas
      Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, announced that Neutrolis and Remora...

      The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer

      Europe
      AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a third-generation, irreversible epidermal growth...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.